Alpha Cognition Inc. SEC filings ACOG
Alpha Cognition Inc. has 216 filings in SEC EDGAR's recent list, going back to Oct 16, 2015. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 23, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jan 13, 2026 | — |
| 424B5 | Prospectus supplement | Oct 1, 2025 | — |
| 424B5 | Prospectus supplement | Sep 30, 2025 | — |
| 424B2 | Prospectus | Aug 29, 2025 | — |
| 424B3 | Prospectus | Aug 29, 2025 | — |
| S-3 | Shelf registration | Aug 22, 2025 | — |
| 424B3 | Prospectus | Aug 5, 2025 | — |
| S-3 | Shelf registration | Jul 21, 2025 | — |
| 424B3 | Prospectus | Jul 17, 2025 | — |
| S-3 | Shelf registration | Jul 1, 2025 | — |
| 424B3 | Prospectus | Jan 15, 2025 | — |
| 424B3 | Prospectus | Jan 15, 2025 | — |
| POS AM | Post-effective amendment | Jan 10, 2025 | — |
| S-1/A | Amended registration statement | Jan 10, 2025 | — |
| POS AM | Post-effective amendment | Dec 31, 2024 | — |
| S-1 | Registration statement | Dec 31, 2024 | — |
| S-8 POS | Post-effective amendment no. 1 to form s-8 | Dec 31, 2024 | — |
| 424B4 | Prospectus | Nov 13, 2024 | — |
| S-1MEF | Registration statement | Nov 12, 2024 | — |
| S-1/A | Amended registration statement | Nov 6, 2024 | — |
| S-1/A | Amended registration statement | Oct 25, 2024 | — |
| 424B3 | Prospectus | Oct 25, 2024 | — |
| S-1 | Registration statement | Oct 16, 2024 | — |
| S-1/A | Amended registration statement | Oct 16, 2024 | — |
| S-8 | Employee stock plan registration | Oct 16, 2024 | — |
| 424B3 | Prospectus | Aug 15, 2024 | — |
| S-1/A | Amended registration statement | Jul 30, 2024 | — |
| S-1 | Registration statement | Jun 14, 2024 | — |
| 424B3 | Prospectus | Jun 10, 2024 | — |
| S-1/A | Amended registration statement | Jun 4, 2024 | — |
| S-1/A | Amended registration statement | May 22, 2024 | — |
| S-1/A | Amended registration statement | May 10, 2024 | — |
| S-1 | Registration statement | Apr 30, 2024 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ACOG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Grapevine, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1655923
- Former names
- Neurodyn Cognition Inc. (until Oct 9, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.